Interface Biologics

📍 Toronto, Canada🗓 Founded 2001👥 10 employees💰 Last funded 2015
Biotechnology Research🌐 interfacebiologics.com
Website LinkedIn
Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.  IBI’s primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices. 
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2001
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Interface Biologics?
Interface Biologics has 1 investors on record on gritt.io.
When did Interface Biologics last raise funding?
The most recent investment in Interface Biologics recorded on gritt.io was in 2015.
When was Interface Biologics founded?
Interface Biologics was founded in 2001.
What industry is Interface Biologics in?
Interface Biologics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Interface Biologics based?
Interface Biologics is headquartered in Toronto, Canada.